Clinical Trials Browser

Unknown × Carcinoma, Non-Small-Cell Lung × Sorafenib × Clear all

NCT00801385 2009-08-25

Sorafenib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Chemotherapy

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00722969 2009-03-03

Erlotinib and Sorafenib in Chemonaive Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung